Newsletter - Banner

Breadcrumb

Asset Publisher

angle-left Behind the Scenes at the RI-MUHC Technology Platforms

Public tours followed the journey of a cancer research sample at the Glen site

Nov. 19, 2019

Source: RI-MUHC. On November 13 the McGill University Health Centre (MUHC) Foundation offered 350 members of the public a fascinating look “Behind the Scenes” at healthcare and research. Activities ranged from hands-on discovery of the role of liquid biopsies in cancer detection to testing the strength of your lungs and understanding why high blood sugar causes kidney disease.

The technology platforms at the Research Institute of the McGill University Health Centre (RI-MUHC) also opened their doors, hosting over 50 participants in an exclusive tour of the Glen site research facilities. To find out how this powerhouse of innovative technologies supports the work of researchers and helps accelerate biomedical research, visitors followed the path of a cancer research sample from platform to platform.

“We wanted to provide participants with firsthand experience of the cutting-edge research carried out at the RI-MUHC,” said Patrice Vaillancourt, manager of operations and platforms, “and meet some of our people who make these technologies work. So I was very happy to hear comments from visitors like, ‘I know how important research is for developing new treatments, but seeing the amazing instruments and learning what they can do from the people who work there makes it so much more real and interesting.’ ”

Read more about Behind the Scenes on the MUHC Foundation website

Shibo Feng, M.Sc. (left), and Min Fu, PhD (right), of the Molecular Imaging Platform, animate the Technology Platforms Kiosk (Behind the Scenes event at the Research Institute of the MUHC, November 13, 2019)
Shibo Feng, M.Sc. (left), and Min Fu, PhD (right), of the Molecular Imaging Platform, animate the Technology Platforms Kiosk (Behind the Scenes event at the Research Institute of the MUHC, November 13, 2019)
Shibo Feng, M.Sc. (left), and Min Fu, PhD (right), of the Molecular Imaging Platform, animate the Technology Platforms Kiosk (Behind the Scenes event at the Research Institute of the MUHC, November 13, 2019)
Shibo Feng, M.Sc. (left), and Min Fu, PhD (right), of the Molecular Imaging Platform, animate the Technology Platforms Kiosk (Behind the Scenes event at the Research Institute of the MUHC, November 13, 2019)
Nick Bertos, PhD, explains to visitors how cancer research samples are processed and stored in the Biobank Platform (Behind the Scenes event at the Research Institute of the MUHC, November 13, 2019)
Nick Bertos, PhD, explains to visitors how cancer research samples are processed and stored in the Biobank Platform (Behind the Scenes event at the Research Institute of the MUHC, November 13, 2019)
Nidia Lauzon, PhD, of the Drug Discovery Platform, explains the role of nuclear magnetic resonance (NMR) spectroscopy in the discovery of novel drugs to treat cancer (Behind the Scenes event at the Research Institute of the MUHC, November 13, 2019)
Nidia Lauzon, PhD, of the Drug Discovery Platform, explains the role of nuclear magnetic resonance (NMR) spectroscopy in the discovery of novel drugs to treat cancer (Behind the Scenes event at the Research Institute of the MUHC, November 13, 2019)
Ari Gritsas, B.Sc., of the Proteomics Platform, describes how mass spectrometry can identify overexpressed proteins in cancer tissues (Behind the Scenes event at the Research Institute of the MUHC, November 13, 2019)
Ari Gritsas, B.Sc., of the Proteomics Platform, describes how mass spectrometry can identify overexpressed proteins in cancer tissues (Behind the Scenes event at the Research Institute of the MUHC, November 13, 2019)